Buy, hold, sell: Why I’m still backing FeverTree

Ketan Patel, co-manager of the UK Equity Growth,tells Money Observer that they seek opportunities in unloved companies with low price/earnings (p/e) ratios, but with great growth prospects. He explains why he is buying Applied Graphene Materials, holding Fever-Tree and selling Luceco.

Link

top